Related references
Note: Only part of the references are listed.
Review
Oncology
Geoffrey Shouse et al.
Summary: Validated metrics for optimizing the selection of older adult patients for Chimeric Antigen Receptor T-cell therapy are lacking, but geriatric assessments and cumulative illness rating scores may be useful tools based on preliminary data. Interventions to enhance outcomes in older adults receiving CART have yet to be identified, while recent data extrapolated from other diseases and therapeutic modalities suggest possible strategies for product selection, toxicity mitigation, coordinated care models, and functional optimization of patients.
CURRENT ONCOLOGY REPORTS
(2022)
Article
Medicine, General & Internal
Raghad Alqazaqi et al.
Summary: This study examines the geographic distribution of CAR-T therapy and bispecific antibodies for multiple myeloma and its impact on access for Black patients. The findings suggest that there may be disparities in accessing advanced clinical trials for new multiple myeloma therapies, particularly for Black populations.
Article
Hematology
Nausheen Ahmed et al.
Summary: CAR T cell therapy has shown disparities in racial/ethnic distribution, socioeconomic strata, and insurance coverage, with African Americans and Hispanics being underrepresented. Patients living farther from treatment centers tend to be from higher socioeconomic backgrounds. Low enrollment of minorities in clinical trials contributes to these disparities, indicating a need for strategies to address the root causes.
TRANSPLANTATION AND CELLULAR THERAPY
(2022)
Article
Medicine, General & Internal
Nikhil C. Munshi et al.
Summary: The phase 2 study confirmed the efficacy and safety of ide-cel in patients with relapsed and refractory myeloma, with a majority of patients achieving responses and 26% achieving MRD-negative status. Despite the high response rate, almost all patients experienced grade 3 or 4 toxic effects, including hematologic toxic effects and cytokine release syndrome.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Oncology
Pashna N. Munshi et al.
Summary: Autologous hematopoietic stem cell transplantation in multiple myeloma patients aged 75 years and above has shown excellent 2-year outcomes, but remains underutilized in this age group with significant racial and gender disparities.
Article
Medicine, General & Internal
Jesus G. Berdeja et al.
Summary: The study aimed to evaluate the safety and clinical activity of cilta-cel in patients with relapsed or refractory multiple myeloma, and the results showed that cilta-cel treatment achieved good efficacy and safety with short treatment duration, deep response, and long duration of response.
Article
Public, Environmental & Occupational Health
Bettina M. Beech et al.
Summary: This article discusses poverty as a multidimensional factor influencing health and how racism contributes to economic and financial inequality, diminishing prospects for health improvement among marginalized racial and ethnic groups. Poverty is a significant challenge globally, with over 40% of the world living in poverty. The U.S. has high rates of poverty, especially in communities of color, due to racist notions and denial of structural racism and classism.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Oncology
Catherine R. Marinac et al.
BLOOD CANCER JOURNAL
(2020)
Article
Oncology
Jeffrey R. Schriber et al.
Article
Hematology
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
(2015)
